Switch to
More onapp

RPG Life Sciences Ltd

RPGLIFE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,435 cr, stock is ranked 923
Moderate RiskStock is 2.62x as volatile as Nifty
873.306.25 (+0.72%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,435 cr, stock is ranked 923
Moderate RiskStock is 2.62x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
27.88
PB RatioPB Ratio
5.61
Dividend YieldDiv. Yield
1.11%
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

RPG Life Sciences Limited is an India-based company, which is engaged in manufacturing and marketing of pharmaceutical products. The Company operates across segments, including Domestic Formulations, International Formulations, Active Pharmaceutical Ingredients (API) and Biotech. It operates through four business units, which include API, Global Generics, Global Formulation and Biotech. The API product line offers a range of synthetic APIs in the general therapeutic category to Europe, Latin America, Asia and the United States markets. Global Generics business unit commercializes finished dosage forms in markets, such as North America, European Union and Australia. Global formulation product line of the Company manufactures and markets finished dosage formulation in domestic and other markets. In Biotechnology space, it offers oncology products through fermentation route. Its portfolio of products include Anastrazole, Exemestane, Lamotrigine Tablet and Azathioprine Tablet.

Investor PresentationView older 

Oct 18, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022330.96376.30390.05443.1510.8129.0140.0051.48
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of share certificate 
Announced OnNov 26, 2022

Please find enclosed herewith intimation for loss of share certificate as received by us from Link Intime India Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record. | Download

Please find enclosed herewith intimation for loss of share certificate as received by us from Link Intime India Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record. | Download

Loss of share certificate 
Announced OnNov 17, 2022

Please find enclosed herewith intimation for loss of share certificate as received by us from Link Intime India Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record. | Download

Please find enclosed herewith intimation for loss of share certificate as received by us from Link Intime India Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record. | Download

Cash Dividend 
Ex. DateJul 14, 2022

Final • Div/Share: ₹ 9.6

See all events